Fleisher Linda, Ruggieri Dominique G, Miller Suzanne M, Manne Sharon, Albrecht Terrance, Buzaglo Joanne, Collins Michael A, Katz Michael, Kinzy Tyler G, Liu Tasnuva, Manning Cheri, Charap Ellen Specker, Millard Jennifer, Miller Dawn M, Poole David, Raivitch Stephanie, Roach Nancy, Ross Eric A, Meropol Neal J
Children's Hospital of Philadelphia, USA; Fox Chase Cancer Center/Temple University Health System, USA.
St. Joseph's University, USA.
Patient Educ Couns. 2014 Jul;96(1):63-71. doi: 10.1016/j.pec.2014.04.009. Epub 2014 Apr 21.
This article describes the rigorous development process and initial feedback of the PRE-ACT (Preparatory Education About Clinical Trials) web-based- intervention designed to improve preparation for decision making in cancer clinical trials.
The multi-step process included stakeholder input, formative research, user testing and feedback. Diverse teams (researchers, advocates and developers) participated including content refinement, identification of actors, and development of video scripts. Patient feedback was provided in the final production period and through a vanguard group (N=100) from the randomized trial.
Patients/advocates confirmed barriers to cancer clinical trial participation, including lack of awareness and knowledge, fear of side effects, logistical concerns, and mistrust. Patients indicated they liked the tool's user-friendly nature, the organized and comprehensive presentation of the subject matter, and the clarity of the videos.
The development process serves as an example of operationalizing best practice approaches and highlights the value of a multi-disciplinary team to develop a theory-based, sophisticated tool that patients found useful in their decision making process. Practice implications Best practice approaches can be addressed and are important to ensure evidence-based tools that are of value to patients and supports the usefulness of a process map in the development of e-health tools.
本文介绍了PRE-ACT(癌症临床试验预备教育)基于网络的干预措施的严格开发过程及初步反馈,该干预措施旨在改善癌症临床试验决策的准备情况。
多步骤过程包括利益相关者投入、形成性研究、用户测试和反馈。不同团队(研究人员、倡导者和开发者)参与其中,包括内容完善、角色识别和视频脚本开发。在最终制作阶段并通过随机试验中的一个先锋组(N = 100)提供了患者反馈。
患者/倡导者确认了参与癌症临床试验的障碍,包括缺乏意识和知识、对副作用的恐惧、后勤方面的担忧以及不信任。患者表示他们喜欢该工具的用户友好性、主题内容的有条理和全面呈现以及视频的清晰度。
开发过程是实施最佳实践方法的一个范例,并突出了多学科团队开发基于理论的复杂工具的价值,患者在其决策过程中发现该工具很有用。实践意义 可以采用最佳实践方法,这对于确保对患者有价值的循证工具以及支持电子健康工具开发过程图的实用性很重要。